XOFLUZA

Film-coated tablet, 40 mg
RxActive license

Active substance (INN)

baloxavir marboxil

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength40 mg
PackagingUkupno 2 film tablete u blisteru (1x2) u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAnti-infectives for systemic use (J05AX25)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateJuly 21, 2022

Analogs in Montenegro

3

Other medicines with the same active substance

Source: CInMED register